Report cover image

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034

Publisher The Business Research Company
Published Oct 06, 2025
Length 363 Pages
SKU # BRC20450895

Description

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global RNA targeting small molecules therapeutics market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for RNA targeting small molecules therapeutics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The RNA targeting small molecules therapeutics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider RNA targeting small molecules therapeutics market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by offering, by therapeutic indication, by application and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by offering, by therapeutic indication, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for RNA targeting small molecules therapeutics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:

1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators; RNA (Ribonucleic Acid) Splicing Modification; Direct RNA (Ribonucleic Acid) Targeting; Other Offerings

2) By Therapeutic Indication: Lung Fibrosis; Cancer; Neurodegenerative Diseases; Autoimmune; Inflammatory; Other Therapeutic Indications

3) By Application: Drug Discovery; Oncology Research; Disease Identification

4) By End User: Hospitals; Research Laboratories; Pharmaceutical and Biotechnology Companies; Other End-Users

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Teva Pharmaceuticals; Cipla Limited; Dr. Reddy’s Laboratories; Zydus Lifesciences

Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Austria; Belgium; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; RNA targeting small molecules therapeutics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

363 Pages
1 Executive Summary
1.1 RNA Targeting Small Molecules Therapeutics – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 RNA Targeting Small Molecules Therapeutics Market Definition And Segmentations
6.4 Market Segmentation By Offering
6.4.1 mRNA (Messenger Ribonucleic Acid) Translation Modulators
6.4.2 RNA (Ribonucleic Acid) Splicing Modification
6.4.3 Direct RNA (Ribonucleic Acid) Targeting
6.4.4 Other Offerings
6.5 Market Segmentation By Therapeutic Indication
6.5.1 Lung Fibrosis
6.5.2 Cancer
6.5.3 Neurodegenerative Diseases
6.5.4 Autoimmune
6.5.5 Inflammatory
6.5.6 Other Therapeutic Indications
6.6 Market Segmentation By Application
6.6.1 Drug Discovery
6.6.2 Oncology Research
6.6.3 Disease Identification
6.7 Market Segmentation By End User
6.7.1 Hospitals
6.7.2 Research Laboratories
6.7.3 Pharmaceutical And Biotechnology Companies
6.7.4 Other End-Users
7 Major Market Trends
7.1 AI-Powered Deep Learning Revolutionizes RNA-Targeted Small Molecule Drug Discovery
7.2 Strategic Alliance To Develop RNA Splicing Modulators For Challenging Diseases
7.3 Strategic Collaboration And Partnership Fueling RNA Targeting Small Molecules Therapeutics
7.4 Focus on Startup-Driven AI Solutions for RNA-Targeted Therapeutics
7.5 Use Of Artificial Intelligence (AI) To Enhance Efficiency Of RNA Targeting Small Molecules
8 Global RNA Targeting Small Molecules Therapeutics Growth Analysis And Strategic Analysis Framework
8.1 Global RNA Targeting Small Molecules Therapeutics PESTEL Analysis
8.1.1 Political
8.1.2 Economic
8.1.3 Social
8.1.4 Technological
8.1.5 Environmental
8.1.6 Legal
8.2 Analysis Of End User (B2B)
8.2.1 Hospitals
8.2.2 Research Laboratories
8.2.3 Pharmaceutical And Biotechnology Companies
8.2.4 Other End-Users
8.3 Global RNA Targeting Small Molecules Therapeutics Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)
8.4.1 Market Drivers 2019 – 2024
8.4.2 Market Restraints 2019– 2024
8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
8.6.1 Quantitative Growth Contributors
8.6.2 Drivers
8.6.3 Restraints
8.7 Global RNA Targeting Small Molecules Therapeutics Total Addressable Market (TAM)
9 Global RNA Targeting Small Molecules Therapeutics Market Segmentation
9.1 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.2 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.3 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.4 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.5 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of mRNA (Messenger Ribonucleic Acid) Translation Modulators, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.6 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of RNA (Ribonucleic Acid) Splicing Modification, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.7 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Direct RNA (Ribonucleic Acid) Targeting, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.8 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Other Offerings, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 RNA Targeting Small Molecules Therapeutics Market, Regional and Country Analysis
10.1 Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.2 Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.2 Market Overview
11.2.1 Region Information
11.2.2 Market Information
11.2.3 Background Information
11.2.4 Government Initiatives
11.2.5 Regulations
11.2.6 Regulatory Bodies
11.2.7 Major Associations
11.2.8 Taxes Levied
11.2.9 Corporate Tax Structure
11.2.10 Investments
11.2.11 Major Companies
11.3 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
11.9.1 Country Information
11.9.2 Market Information
11.9.3 Background Information
11.9.4 Government Initiatives
11.9.5 Regulations
11.9.6 Regulatory Bodies
11.9.7 Major Associations
11.9.8 Taxes Levied
11.9.9 Corporate Tax Structure
11.9.10 Investments
11.9.11 Major Companies
11.10 China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.11 China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.12 China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.15 India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.16 India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
11.19.1 Country Information
11.19.2 Market Information
11.19.3 Background Information
11.19.4 Government Initiatives
11.19.5 Regulations
11.19.6 Regulatory Bodies
11.19.7 Major Associations
11.19.8 Taxes Levied
11.19.9 Corporate Tax Structure
11.19.10 Investments
11.19.11 Major Companies
11.20 Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.23 South Korea Market
11.24 Summary
11.25 Market Overview
11.25.1 Country Information
11.25.2 Market Information
11.25.3 Background Information
11.25.4 Government Initiatives
11.25.5 Regulations
11.25.6 Regulatory Bodies
11.25.7 Major Associations
11.25.8 Taxes Levied
11.25.9 Corporate Tax Structure
11.25.10 Major Companies
11.26 South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.27 South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.28 South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.29 Australia Market
11.30 Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.31 Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.32 Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.33 Indonesia Market
11.34 Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.35 Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.36 Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.6 UK Market
12.7 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.8 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.9 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.10 Germany Market
12.11 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.12 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.14 France Market
12.15 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.16 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.17 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.18 Italy Market
12.19 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.20 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.22 Spain Market
12.23 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.24 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Major companies
13.3 Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.6 Russia Market
13.7 Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.8 Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.4 North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.5 North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.6 North America RNA Targeting Small Molecules Therapeutics Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
14.9.1 Country Information
14.9.2 Market Information
14.9.3 Background Information
14.9.4 Government Initiatives
14.9.5 Regulations
14.9.6 Regulatory Bodies
14.9.7 Major Associations
14.9.8 Taxes Levied
14.9.9 Corporate Tax Structure
14.9.10 Investments
14.9.11 Major Companies
14.10 USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.11 Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.12 USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.13 USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.14 Canada Market
14.15 Summary
14.16 Market Overview
14.16.1 Country Information
14.16.2 Market Information
14.16.3 Background Information
14.16.4 Government Initiatives
14.16.5 Regulations
14.16.6 Regulatory Bodies
14.16.7 Major Associations
14.16.8 Taxes Levied
14.16.9 Corporate Tax Structure
14.16.10 Investments
14.16.11 Major Companies
14.17 Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.19 Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Major Companies
15.3 South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.4 South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.5 South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.6 Brazil Market
15.7 Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.8 Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Major Companies
17.3 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles
18.1 Company Profiles
18.2 F.Hoffmann-La Roche Ltd. (Genentech)
18.2.1 Company Overview
18.2.2 Products And Services
18.2.3 Business Strategy
18.2.4 Financial Overview
18.3 Teva Pharmaceuticals
18.3.1 Company Overview
18.3.2 Products And Services
18.3.3 Financial Overview
18.4 Cipla Limited
18.4.1 Company Overview
18.4.2 Products And Services
18.4.3 Financial Overview
18.5 Dr. Reddy’s Laboratories Ltd
18.5.1 Company Overview
18.5.2 Products And Services
18.5.3 Financial Overview
18.6 Zydus Lifesciences (formerly Cadila Healthcare)
18.6.1 Company Overview
18.6.2 Products and Services
18.6.3 Financial Overview
19 Other Major And Innovative Companies
19.1 Apotex Inc.
19.1.1 Company Overview
19.1.2 Products and Services
19.2 Skyhawk Therapeutics
19.2.1 Company Overview
19.2.2 Products and Services
19.3 STORM Therapeutics
19.3.1 Company Overview
19.3.2 Products and Services
19.4 Arrakis Therapeutics Inc.
19.4.1 Company Overview
19.4.2 Products and Services
19.5 Anima Biotech Inc.
19.5.1 Company Overview
19.5.2 Products and Services
19.6 Ribometrix Inc.
19.6.1 Company Overview
19.6.2 Products and Services
19.7 Accent Therapeutics Inc.
19.7.1 Company Overview
19.7.2 Products and Services
19.8 Promega Corporation
19.8.1 Company Overview
19.8.2 Products and Services
19.9 Bayer AG
19.9.1 Company Overview
19.9.2 Products and Services
19.10 Arrowhead Pharmaceuticals Inc.
19.10.1 Company Overview
19.10.2 Products and Services
19.11 Ionis Pharmaceuticals Inc.
19.11.1 Company Overview
19.11.2 Products and Services
19.12 Alnylam Pharmaceuticals
19.12.1 Company Overview
19.12.2 Products and Services
19.13 Abivax SA
19.13.1 Company Overview
19.13.2 Products and Services
19.14 Remix Therapeutics
19.14.1 Company Overview
19.14.2 Products and Services
19.15 858 Therapeutics Inc.
19.15.1 Company Overview
19.15.2 Products and Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions
22.1 Novartis Acquired Regulus Therapeutics Inc.
23 Recent Developments In The RNA Targeting Small Molecule Therapeutics Market
23.1 FDA Approves First Routine Prophylactic Therapy To Reduce Bleeding In Hemophilia Patients
24 Opportunities And Strategies
24.1 Global RNA Targeting Small Molecules Therapeutics Market In 2029 – Countries Offering Most New Opportunities
24.2 Global RNA Targeting Small Molecules Therapeutics Market In 2029 – Segments Offering Most New Opportunities
24.3 Global RNA Targeting Small Molecules Therapeutics Market In 2029 – Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 RNA Targeting Small Molecules Therapeutics Market, Conclusions And Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us